Pancreatic Cancer News and Research

RSS

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

Assisted living facilities provide housing and care to persons unable to live independently, and who often have increasing medical needs. Disease outbreaks illustrate challenges of maintaining adequate resident protections in these facilities. ... Of the 50 states, 84% specify health-based admissions criteria to assisted living facilities; 60% require licensed health care professionals to oversee medical care; ... There is wide variation in how assisted living facilities are regulated in the United States.

25 Nov 2013

Patients treated with high-risk endoscopic procedure less likely to be admitted in hospital

Patients who seek treatment from physicians who more frequently perform a high-risk endoscopic procedure are less likely to be admitted to the hospital or require a repeat procedure. Unfortunately, 90 percent of physicians performing these procedures do very few of them.

19 Nov 2013

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

According to a long-term women's health study recently published, women in the study who ate a one-ounce serving of tree nuts two or more times a week had a reduced risk of pancreatic cancer compared to those studied who did not include nuts in their diet.

19 Nov 2013

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

The Pancreatic Cancer Action Network has teamed up with the cast of the USA Network primetime show "Royal Pains" to educate fans and the general public about the severity of pancreatic cancer. Mark Feuerstein, who plays Dr. Hank Lawson, the talented and respected doctor behind a Hamptons medical practice, appears in a new public service announcement for the organization with co-stars Paulo Costanzo, Reshma Shetty, Brooke D'Orsay, and Ben Shenkman.

16 Nov 2013

New technique helps fight deadly pancreatic cancer using 2 types of nanoparticles

Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer that uses two different types of nanoparticles, the first type clearing a path into tumor cells for the second, which delivers chemotherapy drugs.

16 Nov 2013

Cells sticking molecule over-produced in rheumatoid arthritis and cancers

A molecule that helps cells stick together is significantly over-produced in two very different diseases - rheumatoid arthritis and a variety of cancers, including breast and brain tumors, concludes a new study. The scientists who made the discovery also found candidate drugs to inhibit the molecule, cadherin-11, one of which is already in a clinical trial.

14 Nov 2013

Dual-wave nanotherapy method improves treatment of deadly pancreatic cancer

A new method of microscopic drug delivery that could greatly improve the treatment of deadly pancreatic cancer has been proven to work in mice at UCLA's Jonsson Comprehensive Cancer Center.

14 Nov 2013

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

Extensive statistical analyses of the mutation distribution in several thousand cancerous tumours make it possible to find cures for types of cancer that cannot be treated today.

13 Nov 2013

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

FibroGen, Inc. (FibroGen), today announced that data from a China-based Phase 2 study of roxadustat (FG-4592), a first-in-class oral compound in late stage development for the treatment of anemia associated with chronic kidney disease (CKD) and end-stage renal disease (ESRD), were presented in an oral session at the 2013 American Society of Nephrology (ASN) Kidney Week in Atlanta, Georgia.

13 Nov 2013

Pancreatic cancer death rates in whites and blacks go in opposite directions

Pancreatic cancer death rates in whites and blacks have gone in opposite directions over the past several decades in the United States, with the direction reversing in each ethnicity during those years.

13 Nov 2013

RNA molecule present in the blood could someday be a diagnostic marker for pancreatic cancer

An Indiana University cancer researcher has demonstrated that a particular molecule is present in the blood of most pancreatic cancer patients, suggesting it could someday be a diagnostic marker for the disease.

8 Nov 2013

Consumption of tree nuts inversely associated with risk of pancreatic cancer in women

In a large prospective study published online in the British Journal of Cancer, researchers looked at the association between nut consumption and risk of pancreatic cancer among 75,680 women in the Nurses' Health Study, with no previous history of cancer.

8 Nov 2013

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

Researchers from the University of Missouri have found a more accurate laboratory method for diagnosing pancreatic cancer, the fourth leading cause of cancer death in the United States. The disease causes more than 38,000 deaths each year in the United States, and kills 94 percent of people with the illness within five years, according to the National Cancer Institute.

7 Nov 2013

NTU establishes new $60 million research institute in Nanomedicine

Nanyang Technological University is giving the development of nanotechnology a big boost, by establishing a new $60 million research institute in Nanomedicine, which focuses on the medical application of nanotechnology. An emerging field in drugs, nanomedicine are made up of tiny nano-sized particles thousands of times smaller than a grain of sand.

5 Nov 2013

Hopes Raised For Early Pancreatic Cancer Detection

...

25 Oct 2013

Study: Investigational drug shows promise against pancreatic cancer

An investigational drug that disrupts tumor blood vessels shows promise against a rare type of pancreatic cancer, scientists at Albert Einstein College of Medicine of Yeshiva University have found. Their results were presented October 20 during a poster session at an international cancer conference.

25 Oct 2013

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

A new study reveals that tumors release factors into the bloodstream that inhibit the repair of damaged muscle fibers, and that this contributes to muscle loss during cancer wasting.

24 Oct 2013

Leukemia drug reverses symptoms of colitis in lab tests

A drug currently on the market to treat leukemia reversed symptoms of colitis in lab tests, according to recently published findings by medical researchers with the University of Alberta.

24 Oct 2013

A simple blood test may reveal the earliest signs of pancreatic cancer

Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always fatal because it isn't usually discovered until it has spread to other parts of the body.

23 Oct 2013

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

An investigational new PARP inhibitor, BMN 673, is showing early responses in patients with heavily pretreated, advanced, BRCA-related cancers of the breast and ovary, according to phase I clinical trial results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

23 Oct 2013

Pancreatic Cancer News and Research

Further Reading

Research roundup: Meeting the needs of assisted living residents; Medicaid expansion and community health centers; money follows the person

Patients treated with high-risk endoscopic procedure less likely to be admitted in hospital

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

Pancreatic Cancer Action Network teams up with Royal Pains cast to educate on pancreatic cancer

New technique helps fight deadly pancreatic cancer using 2 types of nanoparticles

Cells sticking molecule over-produced in rheumatoid arthritis and cancers

Dual-wave nanotherapy method improves treatment of deadly pancreatic cancer

Professor receives NOK 75M grant to develop idea for next generation personalized cancer therapy

FibroGen presents China-based Phase 2 study data of roxadustat for treatment of CKD patients

Pancreatic cancer death rates in whites and blacks go in opposite directions

RNA molecule present in the blood could someday be a diagnostic marker for pancreatic cancer

Consumption of tree nuts inversely associated with risk of pancreatic cancer in women

MU researchers find more accurate laboratory method for diagnosing pancreatic cancer

NTU establishes new $60 million research institute in Nanomedicine

Hopes Raised For Early Pancreatic Cancer Detection

Study: Investigational drug shows promise against pancreatic cancer

Study reveals that tumors factors inhibit repair of damaged muscle fibers during cancer wasting

Leukemia drug reverses symptoms of colitis in lab tests

A simple blood test may reveal the earliest signs of pancreatic cancer

New PARP inhibitor shows early responses in patients with advanced BRCA-related cancers

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News